1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collier, TL; Waterhouse, RN | 1 |
1 other study(ies) available for 1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine and B16 Melanoma
Article | Year |
---|---|
In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET.
Topics: Analysis of Variance; Animals; Brain; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Kidney; Liver; Lung; Male; Melanoma, Experimental; Mice; Mice, Nude; Muscle, Skeletal; Myocardium; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Tissue Distribution; Tomography, Emission-Computed | 1997 |